Breaking News: Olema Oncology Announces Exciting Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)!
Breaking News: Olema Oncology Announces Exciting Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)! Description: SAN FRANCISCO, Jan. 03, 2025 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond,